Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study

Kristina E. Rudd(University of Pittsburgh), Sarah Charlotte Johnson(University of Washington), Kareha M Agesa(University of Washington), Katya Anne Shackelford(University of Washington), Derrick Tsoi(University of Washington), Daniel Kievlan(University of Pittsburgh), Danny V. Colombara(University of Washington), Kevin S Ikuta(University of Washington), Niranjan Kissoon(University of British Columbia), Simon Finfer(UNSW Sydney), Carolin Fleischmann-Struzek(Jena University Hospital), Flávia Ribeiro Machado(Universidade Federal de São Paulo), Konrad Reinhart(Jena University Hospital), Kathy Rowan(London School of Hygiene & Tropical Medicine), Christopher W. Seymour(University of Pittsburgh), R. Scott Watson(Seattle Children's Hospital), T. Eoin West(University of Washington), Fatima Marinho(Universidade de São Paulo), Simon I Hay(University of Washington), Rafael Lozano(University of Washington), Alan D López(The University of Melbourne), Derek C. Angus(University of Pittsburgh), Christopher J L Murray(University of Washington), Mohsen Naghavi(University of Washington)
The Lancet
January 1, 2020
Cited by 7,550Open Access
Full Text

Abstract

BACKGROUND: Sepsis is life-threatening organ dysfunction due to a dysregulated host response to infection. It is considered a major cause of health loss, but data for the global burden of sepsis are limited. As a syndrome caused by underlying infection, sepsis is not part of standard Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) estimates. Accurate estimates are important to inform and monitor health policy interventions, allocation of resources, and clinical treatment initiatives. We estimated the global, regional, and national incidence of sepsis and mortality from this disorder using data from GBD 2017. METHODS: We used multiple cause-of-death data from 109 million individual death records to calculate mortality related to sepsis among each of the 282 underlying causes of death in GBD 2017. The percentage of sepsis-related deaths by underlying GBD cause in each location worldwide was modelled using mixed-effects linear regression. Sepsis-related mortality for each age group, sex, location, GBD cause, and year (1990-2017) was estimated by applying modelled cause-specific fractions to GBD 2017 cause-of-death estimates. We used data for 8·7 million individual hospital records to calculate in-hospital sepsis-associated case-fatality, stratified by underlying GBD cause. In-hospital sepsis-associated case-fatality was modelled for each location using linear regression, and sepsis incidence was estimated by applying modelled case-fatality to sepsis-related mortality estimates. FINDINGS: In 2017, an estimated 48·9 million (95% uncertainty interval [UI] 38·9-62·9) incident cases of sepsis were recorded worldwide and 11·0 million (10·1-12·0) sepsis-related deaths were reported, representing 19·7% (18·2-21·4) of all global deaths. Age-standardised sepsis incidence fell by 37·0% (95% UI 11·8-54·5) and mortality decreased by 52·8% (47·7-57·5) from 1990 to 2017. Sepsis incidence and mortality varied substantially across regions, with the highest burden in sub-Saharan Africa, Oceania, south Asia, east Asia, and southeast Asia. INTERPRETATION: Despite declining age-standardised incidence and mortality, sepsis remains a major cause of health loss worldwide and has an especially high health-related burden in sub-Saharan Africa. FUNDING: The Bill & Melinda Gates Foundation, the National Institutes of Health, the University of Pittsburgh, the British Columbia Children's Hospital Foundation, the Wellcome Trust, and the Fleming Fund.


Related Papers

No related papers found

Powered by citation graph analysis